Safety assessment of sodium zirconium cyclosilicate: A FAERS-based disproportionality analysis
PLOS ONE · 25.03.2025 · 20 (3) · e0320585
DOI: 10.1371/journal.pone.0320585 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 25.03.2025. Verfasst von Yongfei Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu University Key Laboratory of TCM Nourishing Kidney Essence and Anti-Aging Research, The First Clinical Medical College, Nanjing University of…. Hauptthemen laut MEDLINE: Silicates, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Natural Science Foundation of China, Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine.
Abstract (Originalsprache)
Sodium zirconium cyclosilicate (SZC) is a novel therapeutic agent for hyperkalemia. However, limited reports have described its real-world safety. In this study, we used the Food and Drug Administration Adverse Event Reporting System (FAERS) database to evaluate the safety profilet of SZC. This retrospective analysis involved FAERS data from the third quarter of 2018 to the fourth quarter of 2023. A disproportionality analysis, including reporting odds ratio (ROR), proportional reporting ratio (PRR), empirical bayesian geometric mean(EBGM), and bayesian confidence propagation neural network (BCPNN), was conducted to quantify the signals of SZC-related adverse events (AEs). Sex subgroup analyses were also conducted. A total of 1,154 SZC-related AE reports were obtained from the FAERS database. SZC-related AEs primarily targeted 21 system organ classes after simultaneously conforming to the four algorithms. The most common AEs included X-ray gastrointestinal tract abnormalities(ROR = 3888.02[1051.8, 14372.15]) and blood potassium abnormal(ROR = 212.53[134.73, 335.26]), consistent with prior findings and clinical trials. Unexpected significant AEs included ileus (ROR = 27.82[14.44, 53.59]), death (ROR = 17.49[15.7, 19.49]) and congestive cardiac failure (ROR = 16.66[10.94, 25.37]). Sex-based differences were observed for AEs. The median onset time of SZC-related AEs was 33 days. This study confirms common AEs of SZC and identifies new ones, highlighting the need for careful monitoring and facilitating its safe use in clinical settings. However, disproportionality analysis cannot formally prove causation and further studies are needed to confirm these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu University Key Laboratory of TCM Nourishing Kidney Essence and Anti-Aging Research, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
- Zou's Nephrology Medicine Intangible Cultural Heritage Inheritance Studio, Nanjing, China.
ORCID-Profile: Enchao Zhou
Förderung
- National Natural Science Foundation of China
- Jiangsu Natural Science Foundation of China
- Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine
- Jiangsu Province Traditional Chinese Medicine Science and Technology
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Jiangsu Province Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Yu, Y., Zhang, K., Gao, J., Huang, G., Yong, C., Wei, Y., & Zhou, E. (2025). Safety assessment of sodium zirconium cyclosilicate: A FAERS-based disproportionality analysis. PLOS ONE, 20(3), e0320585. https://doi.org/10.1371/journal.pone.0320585
Vancouver
Yu Y, Zhang K, Gao J, Huang G, Yong C, Wei Y, et al. Safety assessment of sodium zirconium cyclosilicate: A FAERS-based disproportionality analysis. PLOS ONE. 2025;20(3):e0320585. doi:10.1371/journal.pone.0320585
BibTeX
@article{Yu2025,
author = {Yu, Yongfei and Zhang, Kaiyu and Gao, Jinglin and Huang, Guoshun and Yong, Chen and Wei, Yuan and Zhou, Enchao},
title = {Safety assessment of sodium zirconium cyclosilicate: A FAERS-based disproportionality analysis},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0320585},
doi = {10.1371/journal.pone.0320585}
}
EUVIMED